Keywords
| 1. | Cotran RS, Pober JS. Endothelial activation and inflammation. ProgImmunol 1989;8:747. ![]() |
| 2. | Pober JS, Cotran RS. The role of endothelial cells in inflammation. Transplantation 1990;50:537-44. ![]() [PUBMED] |
| 3. | Pober JS, Min W, Bradley JR. Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 2009;4:71-95. ![]() [PUBMED] |
| 4. | Hansson GK, Libby P. Schönbeck U, Yan ZQ. Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis. Circ Res 2002;91:281-.-91. ![]() |
| 5. | Steinberg D. Atherogenesis in perspective: Hypercholesterolemia and inflammation as partners in crime. Nat Med 2002;8:1211-7. ![]() |
| 6. | Aird WC. Endothelial cell heterogeneity and Atherosclerosis. Curr Atheroscler Rep 2006;8:69-75. ![]() |
| 7. | Flammer AJ, Lüscher TF. Human endothelial dysfunction: EDRFs. Pflugers Arch 2010;459:1005-13. ![]() |
| 8. | Cooke JP. The pivotal role of nitric oxide for vascular health. Can J Cardiol 2004;20 Suppl B:7B-15B. ![]() |
| 9. | Tellides G, Pober JS. Interferon-gamma axis in graft arteriosclerosis. Circ Res 2007;100:622-32. ![]() |
| 10. | Hansson GK, Jonasson L, Holm J, Clowes MM, Clowes AW. Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ Res 1988;63:712-9. ![]() |
| 11. | Mach B, Steimle V, Martinez-Soria E, Reith W. Regulation of MHC class II genes: Lessons from a disease. Annu Rev Immunol 1996;14:301-31. ![]() |
| 12. | Miller CH. Maher SG. Young HA. Clinical Use of Interferon-gamma. Ann N Y Acad Sci 2009;1182:69-79. ![]() |
| 13. | Billiau A, Matthys P. Interferon-gamma: A historical perspective. Cytokine Growth Factor Rev 2009;20:97-113. ![]() |
| 14. | McLaren JE, Ramji DP. Interferon gamma: A master regulator of atherosclerosis. Cytokine Growth Factor Rev 2009;20:125-35. ![]() |
| 15. | Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007;96:41-101. ![]() |
| 16. | Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997;15:749-95. ![]() |
| 17. | Zohlnhofer D, Richte T, Neumann F, Nuhrenberg T, Wessely R, Brandl R, et al. Transcriptome analysis reveals a role of interferon-gamma in human neointima formation. Mol Cell 2001;7:1059-69. ![]() |
| 18. | Der SD, Zhou A, Williams BR, Silverman RH. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 1998;95:15623-8. ![]() |
| 19. | Roselaar SE, Schonfeld G, Daugherty A. Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J Clin Invest 1995;96:1389-94. ![]() |
| 20. | Roselaar SE, Kakkanathu PX, Daugherty A. Lymphocyte populations in atherosclerotic lesions of apoE-/- and LDL receptor-/- mice: Decreasing density with disease progression. Arterioscler Thromb Vasc Biol 1996;16:1013-8. ![]() |
| 21. | Zhou XH, Stemme S, Hansson GK. Evidence for a local immune response in atherosclerosis: CD4(+) T cells infiltrate lesions of apolipoprotein-E-deficient mice. Am J Pathol 1996;149:359-66. ![]() |
| 22. | Emeson EE, Shen ML, Bell CG, Qureshi A. Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice. Am J Pathol 1996;149:675-85. ![]() |
| 23. | Zhou XH, Paulsson G, Stemme S, Hansson GK. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J Clin Invest 1998;101:1717-25. ![]() |
| 24. | Fong LG, Fong TA, Cooper AD. Inhibition of mouse macrophage degradation of acetyl low density lipoprotein by interferon-γ. J Biol Chem 1990;265:11751-60. ![]() |
| 25. | Li JH, Kluger MS, Madge LA, Zheng L, Bothwell AL, Pober JS. Interferon-γ augments CD95(APO-1/Fas) and procaspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Am J Pathol 2002;161:1485-95. ![]() |
| 26. | Laroux FS, Pavlick KP, Hines IN, Kawachi S, Harada H, Bharwani S, et al. Role of nitric oxide in inflammation. Acta Physiol Scand 2001;173:113-8. ![]() |
| 27. | Kim YM, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997;272:31138-48. ![]() |
| 28. | Javanmard SH, Nematbakhsh M, Mahmoodi F, Mohajeri MR. l-Arginine supplementation enhances eNOS expression in experimental model of hypercholesterolemic rabbits aorta. Pathophysiology 2009;16:9-13. ![]() |
| 29. | Marumo T, Nakaki T, Adachi H, Esumi H, Suzuki H, Saruta T, et al. Nitric oxide synthase mRNA in endothelial cells: Synergistic induction by interferon-gamma, tumor necrosis factor-alpha and lipopolysaccharide and inhibition by dexamethasone. Jpn J Pharmacol 1993;63:327-34. ![]() |
| 30. | Cornicelli JA, Butteiger D, Rateri DL, Welch K, Daugherty A. Interleukin-4 augments acetylated LDL induced cholesterol esterification in macrophages. J Lipid Res 2000;41:376-83. ![]() |
| 31. | Lamas S, Michel T, Collins T, Brenner BM, Marsden PA. Effects of interferon-gamma on nitric oxide synthase activity and endothelin-1 production by vascular endothelial cells. J Clin Invest 1992;90:879-87. ![]() |
| 32. | Morikawa A, Koide N, Kato Y, Sugiyama T, Chakravortty D, Yoshida T, et al. Augmentation of nitric oxide production by gamma interferon in a mouse vascular endothelial cell line and its modulation by tumor necrosis factor alpha and lipopolysaccharide. Infect Immun 2000;68:6209-14. ![]() |
| 33. | Kubes P, Suzuki M, Granger DN. Nitric oxide: An endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci USA 1991;88:4651-5. ![]() |
| 34. | Yamaoka J, Kabashima K, Kawanishi M, Toda K, Miyachi Y. Cytotoxicity of IFN-gamma and TNF-alpha for vascular endothelial cell is mediated by nitric oxide. Biochem Biophys Res Commun 2002;291:780-6. ![]() |